NYSE: ABBV
AbbVie Inc.
Healthcare · Drug Manufacturers - General
Market Cap
$390.82B
52w High
$244.81
52w Low
$181.73
P/E
107.84
Volume
2.44M
Outstanding Shares
1.77B
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 18.75% over the last year. Revenue grew 9.5% over the trailing twelve months. Operating margin moved from 17.56% to 27.6%. Free cash flow grew 35.62% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/FCF range (90th percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at 27.6% — continued expansion would be needed to justify the premium. Revenue growth of 9.5% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
28
Buy
12
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 30, 2026
Q3 FY26 · EPS est $3.78 · Revenue est $16.78B
View
Dividends
$6.74/shareQuarterlyDividend Achiever · 12yrAt RiskABBV pays a dividend with a 3.05% dividend yield, 12 consecutive years of growth, growing at 6.33% annually, covered 1.5× by free cash flow.
Dividend Yield
3.05%
Annual Div / Share
$6.74
5yr CAGR
+6.33%
Doubles every ~11.3yr
Payout Ratio
324.76%
At Risk
Dividend Growth Rate
3yr CAGR
+5.26%
5yr CAGR
+6.33%
10yr CAGR
+12.05%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$3/mo
In 5 yrs
$3/mo
In 10 yrs
$5/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$30/yr $3/mo | $41/yr+36% $3/mo | $56/yr+85% $5/mo |
Yield-on-cost grows from 3.05% → 5.63% over 10yr
Analysis
Dividend Strengths
Dividend Achiever
ABBV has raised its dividend for 12 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 1.5× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 6.33% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
High payout ratio
With 324.76% of earnings paid as dividends, there is limited retained earnings for reinvestment — and a dividend cut becomes more likely if earnings decline.